CN105535562A - 一种治疗半身不遂的中药组合物及其制备方法 - Google Patents
一种治疗半身不遂的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN105535562A CN105535562A CN201610045637.1A CN201610045637A CN105535562A CN 105535562 A CN105535562 A CN 105535562A CN 201610045637 A CN201610045637 A CN 201610045637A CN 105535562 A CN105535562 A CN 105535562A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- hemiplegia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010019468 Hemiplegia Diseases 0.000 title claims abstract description 42
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title description 10
- 238000011282 treatment Methods 0.000 claims abstract description 30
- 239000009636 Huang Qi Substances 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 210000000582 semen Anatomy 0.000 claims description 21
- 241000221377 Auricularia Species 0.000 claims description 20
- 241000522620 Scorpio Species 0.000 claims description 19
- 239000009490 scorpio Substances 0.000 claims description 19
- 235000009508 confectionery Nutrition 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 14
- 239000011812 mixed powder Substances 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 3
- ISQRJFLLIDGZEP-CMWLGVBASA-N Sophoricoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(C=2C(C3=C(O)C=C(O)C=C3OC=2)=O)C=C1 ISQRJFLLIDGZEP-CMWLGVBASA-N 0.000 claims description 2
- ISQRJFLLIDGZEP-KJRRRBQDSA-N Sophoricoside Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1ccc(C=2C(=O)c3c(O)cc(O)cc3OC=2)cc1 ISQRJFLLIDGZEP-KJRRRBQDSA-N 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 29
- 239000008280 blood Substances 0.000 abstract description 22
- 210000004369 blood Anatomy 0.000 abstract description 21
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 8
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 235000012000 cholesterol Nutrition 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 210000004204 blood vessel Anatomy 0.000 abstract description 3
- 230000001413 cellular effect Effects 0.000 abstract description 3
- 230000036737 immune function Effects 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 230000008929 regeneration Effects 0.000 abstract description 2
- 238000011069 regeneration method Methods 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000185686 Apocynum venetum Species 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 235000003417 Plumeria rubra f acutifolia Nutrition 0.000 abstract 1
- 244000040691 Plumeria rubra f. acutifolia Species 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 235000007215 black sesame Nutrition 0.000 abstract 1
- 210000002569 neuron Anatomy 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 15
- 210000003141 lower extremity Anatomy 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 210000003414 extremity Anatomy 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 206010033799 Paralysis Diseases 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 210000001364 upper extremity Anatomy 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000005189 Embolism Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010064012 Central pain syndrome Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010017585 Gait spastic Diseases 0.000 description 1
- 241000305491 Gastrodia elata Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 208000011644 Neurologic Gait disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000003995 blood forming stem cell Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 208000009973 brain hypoxia - ischemia Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000001097 facial muscle Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000037230 mobility Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000000196 olfactory nerve Anatomy 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000011476 stem cell transplantation Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Insects & Arthropods (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗半身不遂的中药组合物,由以下重量份的原料组成:黄芪5-10份、黑木耳10-20份、淫羊藿10-18份、罗布麻7-15份、槐角6-12份、白芷5-10份、熟地10-15份、当归8-13份、鸡血藤5-10份、全蝎5-10份、钩藤10-16份、天麻5-10份、荆芥4-8份、川牛膝8-13份、藏红花5-10份、黑芝麻7-15份,本发明各原料合理配伍,相辅相助,起到活血化瘀、熄风通络、填精补髓的功效,能够软化血管,分解血液内的胆固醇,净化血液,提高新陈代谢,促进神经细胞修复再生长,增强细胞免疫功能,对于半身不遂有很好的疗效,治愈率高,标本兼治,不复发,毒副作用小。
Description
技术领域
本发明涉及中医药技术领域,具体涉及一种治疗半身不遂的中药组合物及其制备方法。
背景技术
半身不遂又叫偏瘫,是指一侧上下肢、面肌和舌肌下部的运动障碍,它是急性脑血管病的一个常见症状。轻度偏瘫病人虽然尚能活动,但走起路来,往往上肢屈曲,下肢伸直,瘫痪的下肢走一步划半个圈,我们把这种特殊的走路姿势,叫做偏瘫步态。严重者常卧床不起,丧失生活能力。
现代医学认为,偏瘫多因脑血管病变所致,如脑血管破裂、栓塞、痉挛等造成中枢神经系统病变而发生头晕、头痛、呕吐、肢体麻木、抽搐、瘫痪、意识不清甚至昏迷等症状,有的患者立即死亡。中医认为,偏瘫的原因是由于湿痰内盛,气虚吹盛,以致肝阳上亢,肝风内动而导致机体的气血阴阳失调。目前,中医治疗半身不遂有中药、针灸、推拿的方法,但是普遍疗效不明显,难以根治;西医治疗多采用脑神经干细胞移植,但干细胞移植方法经目前尚不成熟,疗效也不肯定。半身不遂成为困扰中老年的一项难以攻克的疑难杂症。
发明内容
针对现有技术的不足,本发明提供了一种疗效好,治愈率高的治疗半身不遂的中药组合物及其制备方法。
为实现以上目的,本发明通过以下技术方案予以实现:
一种治疗半身不遂的中药组合物,由以下重量份的原料组成:黄芪5-10份、黑木耳10-20份、淫羊藿10-18份、罗布麻7-15份、槐角6-12份、白芷5-10份、熟地10-15份、当归8-13份、鸡血藤5-10份、全蝎5-10份、钩藤10-16份、天麻5-10份、荆芥4-8份、川牛膝8-13份、藏红花5-10份、黑芝麻7-15份。
优选地,所述的治疗半身不遂的中药组合物,由以下重量份的原料组成:黄芪7份、黑木耳17份、淫羊藿15份、罗布麻11份、槐角8份、白芷6份、熟地11份、当归10份、鸡血藤6份、全蝎8份、钩藤12份、天麻7份、荆芥5份、川牛膝10份、藏红花6份、黑芝麻13份。
优选地,所述的治疗半身不遂的中药组合物,由以下重量份的原料制成:黄芪8份、黑木耳15份、淫羊藿13份、罗布麻10份、槐角9份、白芷7份、熟地12份、当归11份、鸡血藤8份、全蝎7份、钩藤13份、天麻7份、荆芥6份、川牛膝10份、藏红花7份、黑芝麻10份。
优选地,所述槐角为蜜槐角,含槐角苷大于4.0%。
优选地,所述中药组合物为片剂、丸剂、颗粒剂或汤剂。
治疗半身不遂的中药组合物的制备方法,包括以下步骤:
(1)将黑木耳和黑芝麻粉碎,得混合粉料,备用;
(2)将钩藤粉碎,得钩藤粉,备用;
(3)将黄芪、淫羊藿、罗布麻、白芷、熟地、当归、鸡血藤、全蝎、天麻、荆芥、川牛膝、藏红花按照重量份称取,粉碎,加10倍水煎煮1.5h,加入步骤(2)的钩藤粉以及槐角,继续煎煮0.5h,过滤,得滤渣和一道煎煮液,备用;
(4)向步骤(3)的滤渣中加入5倍水,再加入步骤(1)的混合粉料,煎煮0.5h,过滤得二道煎煮液,合并两次煎煮液,加热浓缩为稠膏,备用;
(5)向步骤(4)稠膏中添加适宜辅料制成成品。
本发明中各药物的功效如下:
黄芪:味甘,性温,归肺、脾、肝、肾经,为补益脾气之要药,具有补气升阳、固表止汗,利水消肿、托毒排脓,敛疮生肌的功效。
黑木耳:味甘,性平,入胃、大肠经,具有滋补润燥、养血益胃、活血止血、舒筋活络、润肺润肠的作用,黑木耳所含的植物胶质有较强的吸附力,可吸附残留在人体消化系统内的杂质,清洁血液,增强机体细胞免疫和体液免疫功能。
淫羊藿:味辛、甘,性温,归肝、肾经,具有补肾阳,强筋骨,祛风湿之功效,能改善脑缺血缺氧、降低血液黏度、抑制体外血栓形成、刺激骨髓DNA的合成、增加外周血白细胞及骨髓造血干细胞的数量、提高免疫力、促进骨骼生长、预防骨质疏松、抗炎,抗病毒,抗肿瘤、对抗抗癌药物的副作用。
罗布麻:味甘、苦,性凉,归肝经,具有平抑肝阳,清热利尿之功效,有强心、镇静、抗惊厥、调节免疫等作用。
槐角:味苦,性寒。归肝、大肠经,有凉血止血、清肝明目的功效,能软化血管,降血压,降胆固醇,对治疗冠心病、高血压、脑血管栓塞等症有疗效。
白芷:味辛,性温,入肺、脾、胃经,具有祛风除湿、活血止痛之功效。
熟地:性温,味甘,具有补血养阴,填精益髓的功效。
当归:味甘、辛、苦,性温,归肝、心、脾经,具有补血活血、调经止痛、润燥滑肠的功效,为血中之要药。
鸡血藤:味苦、微甘,性温,归肝、心、肾经,具有行血补血、通经活血的功效。
全蝎:味辛,性平,归肝经,具有息风镇痉,通络止痛,攻毒散结之功效。
钩藤:甘苦;微寒,归肝、心经,具有清热平肝、熄风止痉之功效。
天麻:味甘、微辛,性平,具有平肝息风、祛风止痛的功效,能增加脑血流量,降低脑血管阻力,轻度收缩脑血管,增加冠状血管流量,能降低血压,减慢心率,对心肌缺血有保护作用,天麻多糖有免疫活性。
荆芥:味辛,性温,归肺、肝经,具有镇痰祛风、清热凉血的功效。
川牛膝:味甘、微苦,性平,归肝、肾经,具有逐瘀通经、通利关节、利尿通淋之功效。
藏红花:味甘,性平,活血化瘀,具有凉血解毒,解郁安神之功效。
黑芝麻:味甘,性平,归肝、肾、大肠经,具有补肝肾,益精血,润肠燥的功效,黑芝麻含有的多种人体必需氨基酸,在维生素E和维生素B1的作用参与下,能加速人体的代谢功能;黑芝麻含有的铁和维生素E是预防贫血、活化脑细胞、消除血管胆固醇的重要成分。
有益效果:本发明各原料合理配伍,相辅相助,起到活血化瘀、熄风通络、填精补髓的功效,能够软化血管,分解血液内的胆固醇,净化血液,提高新陈代谢,促进神经细胞修复再生长,增强细胞免疫功能,对于半身不遂有很好的疗效,治愈率高,标本兼治,不复发,毒副作用小,制备方法简单,易实施推广。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1:
一种治疗半身不遂的中药组合物,由以下重量份的原料组成:黄芪8份、黑木耳15份、淫羊藿13份、罗布麻10份、蜜槐角9份、白芷7份、熟地12份、当归11份、鸡血藤8份、全蝎7份、钩藤13份、天麻7份、荆芥6份、川牛膝10份、藏红花7份、黑芝麻10份。
治疗半身不遂的中药组合物的制备方法,包括以下步骤:
(1)将黑木耳和黑芝麻粉碎,得混合粉料,备用;
(2)将钩藤粉碎,得钩藤粉,备用;
(3)将黄芪、淫羊藿、罗布麻、白芷、熟地、当归、鸡血藤、全蝎、天麻、荆芥、川牛膝、藏红花按照重量份称取,粉碎,加10倍水煎煮1.5h,加入步骤(2)的钩藤粉以及槐角,继续煎煮0.5h,过滤,得滤渣和一道煎煮液,备用;
(4)向步骤(3)的滤渣中加入5倍水,再加入步骤(1)的混合粉料,煎煮0.5h,过滤得二道煎煮液,合并两次煎煮液,加热浓缩为稠膏,备用;
(5)向步骤(4)稠膏中添加适宜辅料制成片剂。
实施例2:
一种治疗半身不遂的中药组合物,由以下重量份的原料组成:黄芪7份、黑木耳17份、淫羊藿15份、罗布麻11份、蜜槐角8份、白芷6份、熟地11份、当归10份、鸡血藤6份、全蝎8份、钩藤12份、天麻7份、荆芥5份、川牛膝10份、藏红花6份、黑芝麻13份。
治疗半身不遂的中药组合物的制备方法,包括以下步骤:
(1)将黑木耳和黑芝麻粉碎,得混合粉料,备用;
(2)将钩藤粉碎,得钩藤粉,备用;
(3)将黄芪、淫羊藿、罗布麻、白芷、熟地、当归、鸡血藤、全蝎、天麻、荆芥、川牛膝、藏红花按照重量份称取,粉碎,加10倍水煎煮1.5h,加入步骤(2)的钩藤粉以及槐角,继续煎煮0.5h,过滤,得滤渣和一道煎煮液,备用;
(4)向步骤(3)的滤渣中加入5倍水,再加入步骤(1)的混合粉料,煎煮0.5h,过滤得二道煎煮液,合并两次煎煮液,加热浓缩为稠膏,备用;
(5)向步骤(4)稠膏中添加适宜辅料制成颗粒剂。
实施例3:
一种治疗半身不遂的中药组合物,由以下重量份的原料组成:黄芪5份、黑木耳20份、淫羊藿10份、罗布麻15份、蜜槐角6份、白芷10份、熟地10份、当归13份、鸡血藤5份、全蝎10份、钩藤10份、天麻10份、荆芥4份、川牛膝13份、藏红花5份、黑芝麻15份。
治疗半身不遂的中药组合物的制备方法,包括以下步骤:
(1)将黑木耳和黑芝麻粉碎,得混合粉料,备用;
(2)将钩藤粉碎,得钩藤粉,备用;
(3)将黄芪、淫羊藿、罗布麻、白芷、熟地、当归、鸡血藤、全蝎、天麻、荆芥、川牛膝、藏红花按照重量份称取,粉碎,加10倍水煎煮1.5h,加入步骤(2)的钩藤粉以及槐角,继续煎煮0.5h,过滤,得滤渣和一道煎煮液,备用;
(4)向步骤(3)的滤渣中加入5倍水,再加入步骤(1)的混合粉料,煎煮0.5h,过滤得二道煎煮液,合并两次煎煮液,加热浓缩为稠膏,备用;
(5)向步骤(4)稠膏中添加适宜辅料制成汤剂。
实施例4:
一种治疗半身不遂的中药组合物,由以下重量份的原料组成:黄芪10份、黑木耳10份、淫羊藿18份、罗布麻7份、蜜槐角12份、白芷5份、熟地15份、当归8份、鸡血藤10份、全蝎5份、钩藤16份、天麻5份、荆芥8份、川牛膝8份、藏红花10份、黑芝麻7份。
治疗半身不遂的中药组合物的制备方法,包括以下步骤:
(1)将黑木耳和黑芝麻粉碎,得混合粉料,备用;
(2)将钩藤粉碎,得钩藤粉,备用;
(3)将黄芪、淫羊藿、罗布麻、白芷、熟地、当归、鸡血藤、全蝎、天麻、荆芥、川牛膝、藏红花按照重量份称取,粉碎,加10倍水煎煮1.5h,加入步骤(2)的钩藤粉以及槐角,继续煎煮0.5h,过滤,得滤渣和一道煎煮液,备用;
(4)向步骤(3)的滤渣中加入5倍水,再加入步骤(1)的混合粉料,煎煮0.5h,过滤得二道煎煮液,合并两次煎煮液,加热浓缩为稠膏,备用;
(5)向步骤(4)稠膏中添加适宜辅料制成丸剂。
实施例5:
一种治疗半身不遂的中药组合物,由以下重量份的原料组成:黄芪8份、黑木耳13份、淫羊藿11份、罗布麻9份、蜜槐角7份、白芷7份、熟地10份、当归8份、鸡血藤8份、全蝎7份、钩藤12份、天麻6份、荆芥5份、川牛膝12份、藏红花7份、黑芝麻14份。
治疗半身不遂的中药组合物的制备方法,包括以下步骤:
(1)将黑木耳和黑芝麻粉碎,得混合粉料,备用;
(2)将钩藤粉碎,得钩藤粉,备用;
(3)将黄芪、淫羊藿、罗布麻、白芷、熟地、当归、鸡血藤、全蝎、天麻、荆芥、川牛膝、藏红花按照重量份称取,粉碎,加10倍水煎煮1.5h,加入步骤(2)的钩藤粉以及槐角,继续煎煮0.5h,过滤,得滤渣和一道煎煮液,备用;
(4)向步骤(3)的滤渣中加入5倍水,再加入步骤(1)的混合粉料,煎煮0.5h,过滤得二道煎煮液,合并两次煎煮液,加热浓缩为稠膏,备用;
(5)向步骤(4)稠膏中添加适宜辅料制成颗粒剂。
经过药效的检测以及临床病例发现,实施例1中的中药组合物效果最佳。
临床案例:
病例选择:选择确诊的半身不遂患者45例,其中男性28例,女性17例,年龄在45-70岁之间,其中尚能活动的轻度半身不遂患者34例,完全丧失活动能力的严重半身不遂11例。半身不遂临床症状表现有:轻度半身不遂病人虽然尚能活动,但走起路来,往往上肢屈曲,下肢伸直,瘫痪的下肢走一步划半个圈,严重者常卧床不起,丧失生活能力,口眼喁斜,语言障碍,口角流涎,吞咽困难,并伴有颜面、手足麻木,肢体沉重或手指震颤等。
1.治疗方法:采用本发明实施例1制备的中药片剂,2g/片,每日3次,每次2粒,温水送服,1个月为1疗程,治疗周期为3疗程;
2.疗效判断
治愈:偏瘫肢体能活动自然、灵活,语言表达无困难,生活能自理;
显效:偏瘫肢体肌肉恢复明显,语言表达上不完全流利,生活基本能自理;
有效:偏瘫肢体肌肉有所好转,语言表达不流利,生活不能自理;
无效:临床症状同施治前无明显差异。
3.治疗结果:
服用3疗程后,45例半身不遂患者中,治愈33例,显效9例,有效2例,无效1例,治愈率达73.3%,总有效率97.8%,
典型案例:
案例1:赵某,51岁,上肢屈曲严重,下肢伸直,同时左侧面部肌肉麻痹无力,基本丧失生活自理能力,服用本发明实施例1中的中药片剂2疗程后,左半身疼痛明显减轻,服用3疗程后,左腿活动正常,可做屈膝、弯腰、下蹲等动作,左臂关节活动自然,无痛感,生活能够自理。
案例2:钱某,66岁,半身不遂有两年之久,说话不清,右手手指震颤,无法拿起筷子,进食困难,服用本发明2疗程后,可以拿起筷子,精神气色明显改善,服用3疗程完全痊愈,对话清楚,手持物能力正常。
案例3:张某,61岁,突发脑溢血导致半身不遂,卧床不起,行动完全不能自理,服用本发明实施例1的中药片剂1个疗程后,恢复语言功能但不流利,可下床搀扶行走,服用3疗程后,言语流利,可稍快速走路。
需要说明的是,在本文中,诸如第一和第二等之类的关系术语仅仅用来将一个实体或者操作与另一个实体或操作区分开来,而不一定要求或者暗示这些实体或操作之间存在任何这种实际的关系或者顺序。而且,术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含,从而使得包括一系列要素的过程、方法、物品或者设备不仅包括那些要素,而且还包括没有明确列出的其他要素,或者是还包括为这种过程、方法、物品或者设备所固有的要素。在没有更多限制的情况下,由语句“包括一个……”限定的要素,并不排除在包括所述要素的过程、方法、物品或者设备中还存在另外的相同要素。
以上实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的精神和范围。
Claims (6)
1.一种治疗半身不遂的中药组合物,其特征在于,由以下重量份的原料组成:黄芪5-10份、黑木耳10-20份、淫羊藿10-18份、罗布麻7-15份、槐角6-12份、白芷5-10份、熟地10-15份、当归8-13份、鸡血藤5-10份、全蝎5-10份、钩藤10-16份、天麻5-10份、荆芥4-8份、川牛膝8-13份、藏红花5-10份、黑芝麻7-15份。
2.如权利要求1所述的治疗半身不遂的中药组合物,其特征在于,由以下重量份的原料组成:黄芪7份、黑木耳17份、淫羊藿15份、罗布麻11份、槐角8份、白芷6份、熟地11份、当归10份、鸡血藤6份、全蝎8份、钩藤12份、天麻7份、荆芥5份、川牛膝10份、藏红花6份、黑芝麻13份。
3.如权利要求1所述的治疗半身不遂的中药组合物,其特征在于,由以下重量份的原料组成:黄芪8份、黑木耳15份、淫羊藿13份、罗布麻10份、槐角9份、白芷7份、熟地12份、当归11份、鸡血藤8份、全蝎7份、钩藤13份、天麻7份、荆芥6份、川牛膝10份、藏红花7份、黑芝麻10份。
4.如权利要求1所述的治疗半身不遂的中药组合物,其特征在于,所述槐角为蜜槐角,含槐角苷大于4.0%。
5.如权利要求1所述的治疗半身不遂的中药组合物,其特征在于,所述中药组合物为片剂、丸剂、颗粒剂或汤剂。
6.如权利要求1-4任一所述的治疗半身不遂的中药组合物的制备方法,其特征在于,包括以下步骤:
(1)将黑木耳和黑芝麻粉碎,得混合粉料,备用;
(2)将钩藤粉碎,得钩藤粉,备用;
(3)将黄芪、淫羊藿、罗布麻、白芷、熟地、当归、鸡血藤、全蝎、天麻、荆芥、川牛膝、藏红花按照重量份称取,粉碎,加10倍水煎煮1.5h,加入步骤(2)的钩藤粉以及槐角,继续煎煮0.5h,过滤,得滤渣和一道煎煮液,备用;
(4)向步骤(3)的滤渣中加入5倍水,再加入步骤(1)的混合粉料,煎煮0.5h,过滤得二道煎煮液,合并两次煎煮液,加热浓缩为稠膏,备用;
(5)向稠膏中添加适宜辅料制成成品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610045637.1A CN105535562A (zh) | 2016-01-22 | 2016-01-22 | 一种治疗半身不遂的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610045637.1A CN105535562A (zh) | 2016-01-22 | 2016-01-22 | 一种治疗半身不遂的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105535562A true CN105535562A (zh) | 2016-05-04 |
Family
ID=55815464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610045637.1A Pending CN105535562A (zh) | 2016-01-22 | 2016-01-22 | 一种治疗半身不遂的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105535562A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107441412A (zh) * | 2017-09-06 | 2017-12-08 | 夏季 | 一种治疗半身不遂的药物及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1406609A (zh) * | 2001-08-20 | 2003-04-02 | 赵步长 | 一种可用于治疗中风和胸痹的中药胶囊剂及其制法 |
-
2016
- 2016-01-22 CN CN201610045637.1A patent/CN105535562A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1406609A (zh) * | 2001-08-20 | 2003-04-02 | 赵步长 | 一种可用于治疗中风和胸痹的中药胶囊剂及其制法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107441412A (zh) * | 2017-09-06 | 2017-12-08 | 夏季 | 一种治疗半身不遂的药物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101543610B (zh) | 一种有效治疗痛经的药酒 | |
CN103316145B (zh) | 一种治疗下肢胀痛的中药泡脚液及制备方法 | |
CN104826036A (zh) | 一种治疗乳腺增生的复合中药组合物及制备方法 | |
CN103127326A (zh) | 一种治疗骨关节炎的药物组合物及其制备方法 | |
CN102247497A (zh) | 一种治疗类风湿性关节炎的中成药 | |
CN103239588B (zh) | 一种治疗颈椎病的中药组合物 | |
CN102716409B (zh) | 一种补气养血的中药组合物 | |
CN102406765B (zh) | 一种治疗痤疮的中药组合物 | |
CN104857277A (zh) | 一种溶解血栓的纯中药制剂及其制备方法 | |
CN104491596A (zh) | 一种治疗肝肾阴虚型中风的中药组合物及应用 | |
CN103520649A (zh) | 治疗面部神经炎的中药 | |
CN103251889A (zh) | 一种治疗乳汁不通的中药组合物 | |
CN1076619C (zh) | 配合穴位治疗的灸药 | |
CN105535562A (zh) | 一种治疗半身不遂的中药组合物及其制备方法 | |
CN103157006B (zh) | 治疗骨关节炎的内服中药方剂 | |
CN106361981A (zh) | 一种滋阴壮阳的中药 | |
CN103202985A (zh) | 治疗腰椎、颈椎、坐骨神经、风湿病的中药及其制备方法 | |
CN111265609A (zh) | 一种辅助治疗真性近视的中药组合物及其制备方法 | |
CN102600414B (zh) | 一种治疗颈椎病的中药组合物 | |
CN106138602A (zh) | 一种补肾壮骨酒及其制备方法 | |
CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
CN104116976A (zh) | 治疗膝骨性关节病的外用中药 | |
CN104173775A (zh) | 颈源性头痛中药组合物及制备方法 | |
CN103463463A (zh) | 一种补血活血、祛风除湿的中药制剂 | |
CN102973882A (zh) | 一种治疗颈椎病的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160504 |
|
RJ01 | Rejection of invention patent application after publication |